Efficacy of Nilotinib in Patients with Chronic Myeloid Leukemia in chronic phase unachieved Complete Molecular Response
Not Applicable
- Conditions
- Chronic myelogenous leukemia
- Registration Number
- JPRN-UMIN000006294
- Lead Sponsor
- Hyogo College of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients suspected in AP and BC 2) Pregnant and/or lactating woman 3) Severe psychological disorders 4) Uncontorlled complications
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CMR rate after Nlotinib treatmentat 2-year
- Secondary Outcome Measures
Name Time Method The achievement of CMR time after the administration Nlotinib. CMR rate after Nlotinib treatmentat 1-year. Correlate trough levels of Nlotinib with clinical response.